Issue 3/2020
Content (11 Articles)
What Is the Optimal Surveillance Strategy for Non-dysplastic Barrett’s Esophagus?
Ying Gibbens, Prasad G. Iyer
Enteric Hyperoxaluria and Kidney Stone Management in Inflammatory Bowel Disease
Elissa Lin, Joseph Xu, Menghan Liu, Lama Nazzal, Seymour Katz
Obscure Gastrointestinal Bleeding Due to Colonic Source
Robert W. Klapheke, Ethan Bortniker
Evidence Supporting High-Dose Use of Biologics in Clinical Practice
Sarah E. Shannahan, Konstantinos Papamichael, Adam S. Cheifetz
Update on Pregnancy in Patients with IBD
Rachel W. Winter, Sonia Friedman
Novel Therapeutics for the Treatment of IBD: Current Status and Future Directions
Rocio Sedano, Ahmed Almradi, Christopher Ma, Vipul Jairath, Brian G. Feagan
Inflammatory Bowel Disease Therapy and Venous Thromboembolism
Thomas Lambin, Adam S. Faye, Jean-Frédéric Colombel
Update on the Management of Helicobacter pylori Infection
Nasir Saleem, Colin W. Howden
Gastritis: An Update in 2020
Massimo Rugge, Kentaro Sugano, Diana Sacchi, Marta Sbaraglia, Peter Malfertheiner
7RECENT Advances in Endoscopic Treatments for Gastroesophageal Reflux Disease
Farhan Quader, C. Prakash Gyawali
Correction to: RECENT Advances in Endoscopic Treatments for Gastroesophageal Reflux Disease
Farhan Quader, C. Prakash Gyawali